Cell and Gene Therapy CDMO Market Evolves with Regulatory Standardization
The global cell and gene therapy CDMO market was valued at USD 4,986.2 million in 2023 and is anticipated to reach USD 27,449.9 million by 2030, growing at a compound annual growth rate (CAGR) of 27.6% from 2024 to 2030. The market is witnessing strong growth during the forecast period, primarily driven by the expanding pipeline of cell and gene therapy products, increasing focus of...
0 Commentarios 0 Acciones 208 Views 0 Vista previa